Cumulative incidence rates of the mucopolysaccharidoses in Germany
- PMID: 16435194
- DOI: 10.1007/s10545-005-0112-z
Cumulative incidence rates of the mucopolysaccharidoses in Germany
Abstract
In order to estimate the cumulative incidence rates of the mucopolysaccharidoses (MPS) in Germany, a retrospective epidemiological survey covering the period between 1980 and 1995 was implemented. Multiple ascertainment sources were used to identify affected patients. A prevalence of approximately 0.69 cases per 100,000 births was obtained for MPS I (Hurler phenotype). Within the study period, 4 patients with Hurler/Scheie phenotype and 7 cases with Scheie disease were detected. The cumulative incidence for MPS II (Hunter syndrome) was estimated as 0.64 cases per 100,000 births (1.3 cases per 100,000 male live births); that for MPS III (Sanfilippo syndrome types A, B and C) as 1.57 cases in 100,000 births; that for MPS IV A (Morquio syndrome) as 0.38 cases in 100,000; and that for MPS VI (Maroteaux-Lamy syndrome) as 0.23 cases per 100,000 births. Two cases of MPS IVB (beta-galactosidase deficiency) have been identified, but no patients with MPS VII or MPS IX. A relatively high number of patients with MPS IIIB, MPS IVA and MPS VI were of Turkish origin. The crude rate for all types of mucopolysaccharidoses is approximately 3.53 cases in 100,000 live births. The cumulative incidence pattern of MPS in Germany was compared with the corresponding rates among other industrial nations obtained from recent literature: the crude cumulative rates for all types of mucopolysaccharidoses (3.4-4.5 in 100,000 live births) were similar among all published populations; however, different frequencies of the various forms of MPS were observed.
Similar articles
-
Incidence of the mucopolysaccharidoses in Northern Ireland.Hum Genet. 1997 Dec;101(3):355-8. doi: 10.1007/s004390050641. Hum Genet. 1997. PMID: 9439667
-
Incidence of the mucopolysaccharidoses in Western Australia.Am J Med Genet A. 2003 Dec 15;123A(3):310-3. doi: 10.1002/ajmg.a.20314. Am J Med Genet A. 2003. PMID: 14608657 Review.
-
Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004.Am J Med Genet A. 2009 May;149A(5):960-4. doi: 10.1002/ajmg.a.32781. Am J Med Genet A. 2009. PMID: 19396827
-
Prevalence rates of mucopolysaccharidoses in Poland.J Appl Genet. 2015 May;56(2):205-10. doi: 10.1007/s13353-014-0262-5. Epub 2014 Dec 4. J Appl Genet. 2015. PMID: 25472774 Free PMC article.
-
Mucopolysaccharidoses and the eye.Surv Ophthalmol. 2006 Jan-Feb;51(1):1-17. doi: 10.1016/j.survophthal.2005.11.007. Surv Ophthalmol. 2006. PMID: 16414358 Review.
Cited by
-
Hip pathologies in mucopolysaccharidosis type III.J Orthop Surg Res. 2021 Mar 19;16(1):201. doi: 10.1186/s13018-021-02340-6. J Orthop Surg Res. 2021. PMID: 33741007 Free PMC article.
-
Clinical and biochemical studies in mucopolysaccharidosis type II carriers.J Inherit Metab Dis. 2009 Dec;32(6):732-738. doi: 10.1007/s10545-009-1275-9. Epub 2009 Oct 10. J Inherit Metab Dis. 2009. PMID: 19821143
-
Impact of enzyme replacement therapy on linear growth in Korean patients with mucopolysaccharidosis type II (Hunter syndrome).J Korean Med Sci. 2014 Feb;29(2):254-60. doi: 10.3346/jkms.2014.29.2.254. Epub 2014 Jan 28. J Korean Med Sci. 2014. PMID: 24550654 Free PMC article.
-
Methods of neurodevelopmental assessment in children with neurodegenerative disease: Sanfilippo syndrome.JIMD Rep. 2014;13:129-37. doi: 10.1007/8904_2013_269. Epub 2013 Nov 5. JIMD Rep. 2014. PMID: 24190801 Free PMC article.
-
Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.Orphanet J Rare Dis. 2011 Aug 10;6:55. doi: 10.1186/1750-1172-6-55. Orphanet J Rare Dis. 2011. PMID: 21831279 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical